Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Beyond Kidney Function: Unlocking New Biomarkers in
IgA Nephropathy

Learn how existing and emerging
biomarkers have the potential to improve
outcomes for patients with IgA
nephropathy

Several biomarkers of kidney function, such as proteinuria and eGFR, are considered standard in the management of IgA nephropathy. In this brief overview, Dr. Richard Lafayette discusses the potential role of emerging biomarkers in diagnosis, prognosis, treatment selection, and treatment response.1

card clock image 00:08:35

References: 1. Selvaskandan H, Shi S, Twaij S, Cheung CK and Barratt J (2020) Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management. Front. Immunol. 11:572754. https://doi.org/10.3389/fimmu.2020.572754